Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
21.08.2023 21:30:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CELL, AEL, RETA

NEW YORK, Aug. 21, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

PhenomeX Inc. (NASDAQ: CELL)'s sale to Bruker Corporation for $1.00 per share. If you are a PhenomeX shareholder, click here to learn more about your rights and options.

American Equity Investment Life Holding Company (NYSE: AEL)'s sale to Brookfield Reinsurance. As part of the agreement, each American Equity shareholder will receive $38.85 per share in cash and 0.49707 of a Brookfield Asset Management Ltd. class A limited voting share per share of American Equity. If you are an American Equity shareholder, click here to learn more about your rights and options. 

Reata Pharmaceuticals, Inc. (NASDAQ: RETA)'s sale to Biogen Inc. for $172.50 per share in cash. If you are a Reata shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-cell-ael-reta-301905831.html

SOURCE Halper Sadeh LLP

Nachrichten zu Reata Pharmaceuticals Inc (A)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Reata Pharmaceuticals Inc (A)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!